OBLEJARNE
At the conclusion of this activity, the parti I
CATEGORY 1 CME FOR
involved in neuropathic pain transmission;
PHYSICIANS The UCLA Neuropsychiatric Institute desig-
nates this educational activity for a maximum
of 3 hours of Category 1 credit toward the
California Medical Association's Certification
• Identify clinical considerations when
selecting an analgesic for treating chronic
MANDATORY CONTINUING
• Discuss the integration of biopsychosocial
EDUCATION FOR PSYCHOLOGISTS
pharmacologic therapies into primary care
now receive CME certificates for their contin-
ACCREDITATION EDUCATIONAL GRANTOR
This activity is supported by an unrestricted
educational grant from Eli Lilly and Company.
for physicians. The UCLA Neuropsychiatric
DISCLOSURE INFORMATION
content, quality and scientific integrity of
It is the policy of the UCLA Neuropsychiatric
Institute to ensure balance, independence,
and scientific rigor in all educational activities.
Any significant financial interest or any other
relationship a faculty member may have with
product(s) or device(s) must be disclosed to
the participants at the time of the activity. The faculty has disclosed the following:Gary J. Bennett, PhD
of drugs. Not all agents and/or protocols
Has received research grant support from:
Endo Pharmaceuticals, Guilford Pharma-ceuti-
approved by the FDA. Physicians should note
cals Inc., Hypnion, Inc., Pfizer Inc.
that the use of these agents outside current
approved labeling is considered experimental
Avigen, Inc., Novartis Pharmaceuticals.
and are advised to consult current prescribing
information for these products. The faculty is
Michael Byas-Smith, MD
required to disclose their discussion of drugs
Has reported no actual or potential conflict of
or medical devices that are unlabeled, investi-
interest in relation to this activity.
gational, or not approved for the use that is
David A. Fishbain, MD
Has served as a consultant for Eli Lilly and Co.
The contributing faculty developed the content
Has participated in speakers’ bureau for:
independently. All materials are included with
Lilly and Co., Endo Pharmaceuticals.
permission. The opinions expressed are those
Scott M. Fishman, MD
of the faculty and are not to be construed as
Has received research grant support from:
those of the educational sponsor or grantor.
Elan Pharmaceuticals, Endo Pharmaceuticals,
Faculty have disclosed the following:
Janssen Pharmaceutica, Inc., Merck & Co.,
Inc., Pfizer Inc., Purdue Pharma, L.P. Gary J. Bennett, PhD
Off-label uses of dextromethorphan, keta-
Has served as a consultant for: Cephalon, Elan
mine, amantadine, memantine, tricyclic antide-
pressants, venlafaxine, lidocaine, tocainide,
mexiletine, antiepileptics, ziconotide, ethosux-
Inc., Merck & Co., Inc., Pfizer Inc., Purdue
Has participated in speakers’ bureau for: Elan
David A. Fishbain, MD
Off-label uses of fluoxetine, milnacipran,
Janssen Pharmaceutica, Inc., Merck & Co.,
venlafaxine, tricyclic antidepressants, and
Inc., Pfizer Inc., Purdue Pharma, L.P.
selective serotonin reuptake inhibitors are
Rollin M. Gallagher, MD, MPH
Has served as a consultant for: Eli Lilly and Co.,
Scott M. Fishman, MD
Endo Pharmaceuticals, Janssen Pharmaceutica,
Off-label uses of valproic acid, phenytoin,
Has received research grant support from: Eli
zonisamide, tricyclic antidepressants, selective
serotonin reuptake inhibitors, dexamethasone,
baclofen, capsaicin cream, clonidine, opioids,
NLABELED USES/ INVESTIGATIONAL USES/ NOT YET APPROVED COMMERCIAL PRODUCTS The audience is advised that one or more
sections in this educational activity may contain
references to unlabeled or unapproved uses
CUMC CELEBRATES acknowledges faculty, staff, and students at Columbia University Medical Center who receive major research grants, who earn prestigious honors, who are elected to honorary societies, or who take leadership positions in professional organizations. Celebrates also gratefully acknowledges the gifts made by donors and friends of the Medical Center and highlights faculty who have app
How has it come to pass that in fin-de-siècle America, where every child from preschoolonward can recite the ‘anti-drug’ catechism by heart, millions of middle- and upper-middle class children are being legally drugged with a substance so similar to cocainethat, as one journalist accurately summarized the science, ‘it takes a chemist to tell theRitalin® is a popular pharmaceutical th
OBLEJARNE